2012 Lasker Awards Honor Scientists for Groundbreaking Medical ResearchMarketWatch (press release)–Roy Calne and Thomas Starzl for the development of liver transplantation, which has restored normal life to thousands of patients with end-stage liver d…
2012 Lasker Awards Honor Scientists for Groundbreaking Medical Research
NEW YORK , Sept. 10, 2012 /PRNewswire/ — The Albert and Mary Lasker Foundation, which for 67 years has championed the greatest advances in medical research, announced today the winners of the 2012 Lasker …
Opto Circuits gets DCGI nod for heart device – Moneycontrol.com
Opto Circuits gets DCGI nod for heart deviceMoneycontrol.comMedical equipment maker Opto Circuits today said it has received approval from India's health regulator for a medical device for heart patients, following which it has launched the product…
New Drug Helps Child Survive Kidney Disease
A kidney transplant may sound like the perfect solution for a North Texas child battling a rare kidney disease. But until recently, it has not been an option for 5-year-old Aiden Cross.
Opto Circuits' arm launches new drug eluting stent – Business Standard
Business StandardOpto Circuits' arm launches new drug eluting stentBusiness Standard(OEHL) a subsidiary of Bangalore-based medical devices maker Opto Circuits (India) Ltd.has launched its first Sirolimus Drug Eluting Stent (DES), E-MAGIC® Plus. Th…
Death Row Unlikely to Be Source for Organ Donations – Texas Tribune
Death Row Unlikely to Be Source for Organ DonationsTexas TribuneThe prospect of death row organ donation, though, prompts several questions, said Dr. David Orentlicher, a co-director of the Hall Center for Law and Health at Indiana University's Rob…
Opto Circuits receives DCGI license for sale of sirolimus drug eluting stent … – pharmabiz.com
Opto Circuits receives DCGI license for sale of sirolimus drug eluting stent …pharmabiz.comOpto Eurocor Healthcare Limited (OEHL), a subsidiary of Opto Circuits (India) Ltd., launched its first Sirolimus Drug Eluting Stent (DES), E-MAGIC Plus on rece…
New hope for people with fatal lung cancer – Times of India
New hope for people with fatal lung cancerTimes of India"This study clearly shows that squamous cell carcinoma, like lung adenocarcinoma, is a cancer with diverse genomic causes, many of which are potentially susceptible to drug inhibition," …
Opto Eurocor Healthcare launches its first Sirolimus Drug Eluting Stent – Equity Bulls
Opto Eurocor Healthcare launches its first Sirolimus Drug Eluting StentEquity BullsOpto Eurocor Healthcare Limited (OEHL), a subsidiary of Opto Circuits (India) Ltd has launched its first Sirolimus Drug Eluting Stent (DES), E-MAGIC® Plus on receipt of…
Cipla wins Tarceva patent case against Roche – pharmabiz.com
Cipla wins Tarceva patent case against Rochepharmabiz.comIn a landmark judgement, the Delhi High Court on September 7 dismissed Swiss drug major Hoffmann-La Roche's patent case against India's generic drug major Cipla Ltd for its lung cancer dr…